Cytokine Release Syndrome Monitoring: A Digital Health Solution To Advance Immunotherapy Care

Here we introduce an innovative risk-monitoring solution aimed at mitigating Cytokine Release Syndrome (CRS), a critical complication in immunotherapy that often leads to prolonged hospitalization. Utilizing the Connect platform, the solution continuously collects patient data to develop predictive algorithms for early CRS detection. By integrating AI-driven analysis, healthcare providers can assess adverse events (AEs) in real-time.

This approach not only reduces the financial burden of immunotherapy by supporting outpatient care but also enhances patient safety and comfort through minimized hospital stays. Furthermore, it expands clinical trial accessibility by enabling remote participation and provides valuable clinical insights via objective, continuous data collection. Overall, this risk-monitoring solution promises significant advancements in managing CRS, improving patient outcomes, and streamlining healthcare processes.